AIMCA
SCPH

Alberta Investment Management Corp (AIMCo)’s scPharmaceuticals SCPH Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-111,410
Closed -$793K – 1048
2023
Q3 		$793K Hold
111,410
– – 0.01% 702
2023
Q2 		$1.14M Buy
+111,410
New +$1.16M 0.01% 718

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s SCPH Position: Q4 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of scPharmaceuticals (SCPH) in Q4 2023, closing a stake of 111,410 shares — an estimated $793K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in SCPH in Q2 2023 and held it in 2 quarters. The position peaked at $1.14M in Q2 2023. 81 funds tracked by Wall St. Rank hold SCPH as of Q4 2023.

  • Alberta Investment Management Corp (AIMCo) reported no remaining scPharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 111,410 scPharmaceuticals shares in Q4 2023, an estimated $793K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in scPharmaceuticals in Q2 2023 and held it in 2 quarters.
  • Alberta Investment Management Corp (AIMCo)'s scPharmaceuticals position peaked at $1.14M in Q2 2023.
  • 81 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q4 2023, filed 12 Feb 2024.